Home > Insider Trading > Filing (0000899243-22-010795)

Filing Details

Accession Number:: 0000899243-22-010795
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-11 21:00:17
Reporting Period:: 2022-03-10

Accepted Time:: 2022-03-11 21:00:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1403752	Zymeworks Inc.	ZYME	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1761857	A Neil Klompas	C/O Zymeworks Inc. 114 East 4Th Avenue, Suite 800 Vancouver A1 V5T 1G4	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares	Acquisiton	2022-03-10	2,500	$0.00	13,547	No	4	M	Direct
Common Shares	Acquisiton	2022-03-10	2,708	$0.00	16,255	No	4	M	Direct
Common Shares	Disposition	2022-03-10	2,979	$6.88	13,276	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Restricted Stock Unit	Disposition	2022-03-10	2,500	$0.00	2,500	$0.00
Common Shares	Restricted Stock Unit	Disposition	2022-03-10	2,708	$0.00	2,708	$0.00
Common Shares	Stock Option (Right to Buy)	Acquisiton	2022-03-10	200,000	$0.00	200,000	$7.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,500		No	4	M	Direct
5,417		No	4	M	Direct
200,000	2032-03-09	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	700	Indirect	Held by spouse

Footnotes

Represents common shares issued upon vesting of one third of the restricted stock units ("RSUs") granted on March 10, 2020.
Represents common shares issued upon vesting of one third of the RSUs granted on March 10, 2021.
Represents common shares sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs. Pursuant to the terms of the applicable RSU grant agreement (each, a "Grant Agreement"), effective on the grant date of the RSUs, the Reporting Person adopted a 10b5-1 plan pursuant to which the Reporting Person elected to sell shares to cover tax withholding obligations and other applicable fees in accordance with the terms of the Grant Agreement. The Reporting Person is subject to a Lock Up Agreement that expires on March 27, 2022. The sale of shares is a permissible exemption under the terms of the Lock Up Agreement. The remaining shares held by the Reporting Person following this sale remain subject to the terms of the Lock Up Agreement.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.83 to $6.97, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
The RSUs were granted on March 10, 2020 and vest in three equal annual instalments beginning on March 10, 2021.
The RSUs were granted on March 10, 2021 and vest in three equal annual instalments beginning on March 10, 2022.
Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.